{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/fortreas-operational-excellence-cell-therapy-clinical-trials#webpage",
"url": "https://www.fortrea.com/insights/fortreas-operational-excellence-cell-therapy-clinical-trials",
"name": "Fortrea’s operational excellence in cell therapy clinical trials",
"description": "This Fortrea white paper explores operational excellence in cell therapy clinical trials and the specialized strategies required to execute complex cell therapy development programs. The content focuses on operational excellence in cell therapy clinical trials, study execution, patient recruitment, site selection, cell therapy logistics, regulatory guidance, medical monitoring, long-term follow-up, and vendor management associated with advanced cell therapy research. The white paper highlights factors related to patient-centric solutions, cell journey logistics, site performance, study startup processes, clinical data management, monitoring complexities, and operational coordination affecting cell therapy clinical trial execution. Fortrea discusses operational and clinical perspectives designed to support efficient study delivery, strengthen execution strategies, and improve oversight across complex cell therapy programs. By integrating patient recruitment strategies, cell therapy logistics, site management, and long-term follow-up planning, the white paper provides insights into operational excellence in cell therapy clinical trials and the operational frameworks supporting successful cell therapy development."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "Fortrea’s operational excellence in cell therapy clinical trials",
"item": "https://www.fortrea.com/insights/fortreas-operational-excellence-cell-therapy-clinical-trials"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/fortreas-operational-excellence-cell-therapy-clinical-trials#whitepaper",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/fortreas-operational-excellence-cell-therapy-clinical-trials#webpage"
},
"headline": "Operational Excellence in Cell Therapy Clinical Trials & Study Execution Strategies | Fortrea White Paper",
"description": "This Fortrea white paper explores operational excellence in cell therapy clinical trials and the specialized strategies required to execute complex cell therapy development programs. The content focuses on operational excellence in cell therapy clinical trials, study execution, patient recruitment, site selection, cell therapy logistics, regulatory guidance, medical monitoring, long-term follow-up, and vendor management associated with advanced cell therapy research. The white paper highlights factors related to patient-centric solutions, cell journey logistics, site performance, study startup processes, clinical data management, monitoring complexities, and operational coordination affecting cell therapy clinical trial execution. Fortrea discusses operational and clinical perspectives designed to support efficient study delivery, strengthen execution strategies, and improve oversight across complex cell therapy programs. By integrating patient recruitment strategies, cell therapy logistics, site management, and long-term follow-up planning, the white paper provides insights into operational excellence in cell therapy clinical trials and the operational frameworks supporting successful cell therapy development.",
"genre": "White Paper",
"image": {
"@type": "ImageObject",
"url": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png"
},
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2025-11-04",
"dateModified": "2025-11-04",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2025-11/operational-excellence-cell-therapy-trials.pdf",
"encodingFormat": "application/pdf"
}
}
]
}